Zimmer Biomet and Stryker are among the companies buying.

Chris Newmarker

The M&A frenzy in the medical device industry may be losing a bit of steam, but that hasn't stopped medical device companies from engaging in smaller deals to snap up new technologies and capabilities. 

Here are three recent deals in the orthopedics space that stand out:

1. Zimmer Biomet Picks Up 3-D Range-of-Motion Simulation Tech 

The Warsaw, IN-based ortho giant recently announced that it is buying Clinical Graphics for an undisclosed sum. Clinical Graphics's 3D range-of-motion simulation technology shows promise when it comes to informing treatment decisions for common hip conditions requiring early intervention. "3D imaging represents the next generation of treating joint pain, and we're excited to team up with Clinical Graphics and integrate our technologies to further enhance the clinical utility of our market leading hip portfolio," Dan Williamson, group president of joint reconstruction at Zimmer Biomet, said in a news release. 

2. Stryker Buys Tech for Extremety Procedures

Stryker meanwhile has agreed to buy the assets of Restore Surgical (Houston), which does business as Instratek. The deal, expected to close in the fourth quarter of 2016, allows Stryker to acquire a portfolio of pstaple and hammertoe implants, as well as minimally invasive soft tissue recession instrumentation used in foot, ankle and upper extremity procedures. "This acquisition supports our commitment to growth in extremities with products that complement our existing portfolio, strengthen our leadership in the forefoot segment and provide immediate access into minimally invasive soft tissue recession procedures," David Floyd, Stryker's orthopedics group president, said in a news release.

3. Stryker Purchases Sports Injury Tech

Stryker also recently announced that its endoscopy division has bought Ivy Sports Medicine and its minimally invasive meniscal repair platform. The deal also includes Ivy Sports Medicine's FDA-approved collagen meniscus implant, an all-inside repair device, as well as an inside-out meniscal suturing platform for treating the sports knee injury. "This is an area of sports medicine where there is continued opportunity to address unmet customer needs. The Ivy portfolio provides a unique platform for us to build upon as we seek to continue advancing the treatment of meniscal injuries," Matt Moreau, vice president and general manager of Stryker's sports medicine business, said in a news release. 

Chris Newmarker is senior editor of Qmed. Follow him on Twitter at @newmarker.

Like what you're reading? Subscribe to our daily e-newsletter.